Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics

This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT

URLs:
Tickets: https://go.evvnt.com/1875091-2?pid=10297 
Virtual: https://go.evvnt.com/1875091-3?pid=10297 

Date and Time: On Thu, 09 May 2024 07:30 - Fri, 10 May 2024 16:45

Category: Conferences | Science, Health and Medicine | Radiology

Prices:
Practicing Physician/Industry: USD 1395.00,
Military/Retired/Scientist/VA: USD 1295.00,
PA/Nurse: USD 1195.00,
Resident*/Fellow*: USD 1095.00,
Technologist: USD 995.00

Speakers: Phillip Kuo, MD, PhD, FACR, Andrew Quon, MD, Don Yoo, MD